FindTrial
Sign In

Measuring Harmful Chemicals in the Blood of People with Type 2 Diabetes: Comparing Non-Obese and Obese Patients

Evaluation of Serum Persistant Organic Pollutants (POPs) levels in Non - Obese and Obese Type 2 Diabetes Mellitus patients - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/09/093986
Enrollment
100
Registered
2025-09-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Dr Gowsikan K
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Group 1 (Non - Obese T2DM): Newly diagnosed T2DM patients with BMI of less than 25 kg/m2. 2. Group 2 (Obese T2DM): Newly diagnosed T2DM patients with BMI of more than or equal to 25 kg/m2.

Exclusion criteria

Exclusion criteria: 1. History of chronic disorders such as renal & hepatic insufficiency and cancer. 2. Intake of metformin and topiramate or bariatric surgery.

Design outcomes

Primary

MeasureTime frame
Difference in mean/median serum POPs levels (?g/L) in non-obese and obese T2DM.Timepoint: Baseline.—

Secondary

MeasureTime frame
Difference in mean/median HOMA beta and HOMA IR indices in non obese and obese T2DM.Timepoint: Baseline.;Association of serum POP levels with markers of beta cell dysfunction and insulin resistance in non obese and obese T2DM.Timepoint: Baseline.—

Countries

India

Contacts

Public ContactDr Gowsikan K

Maulana Azad Medical College and associated Lok Nayak Hospital

arpita.lhmc@gmail.com9999718289

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026